» Articles » PMID: 25185130

Age-specific Differences Between Conventional and Ambulatory Daytime Blood Pressure Values

Abstract

Mean daytime ambulatory blood pressure (BP) values are considered to be lower than conventional BP values, but data on this relation among younger individuals <50 years are scarce. Conventional and 24-hour ambulatory BP were measured in 9550 individuals not taking antihypertensive treatment from 13 population-based cohorts. We compared individual differences between daytime ambulatory and conventional BP according to 10-year age categories. Age-specific prevalences of white coat and masked hypertension were calculated. Among individuals aged 18 to 30, 30 to 40, and 40 to 50 years, mean daytime BP was significantly higher than the corresponding conventional BP (6.0, 5.2, and 4.7 mm Hg for systolic; 2.5, 2.7, and 1.7 mm Hg for diastolic BP; all P<0.0001). In individuals aged 60 to 70 and ≥70 years, conventional BP was significantly higher than daytime ambulatory BP (5.0 and 13.0 mm Hg for systolic; 2.0 and 4.2 mm Hg for diastolic BP; all P<0.0001).The prevalence of white coat hypertension exponentially increased from 2.2% to 19.5% from those aged 18 to 30 years to those aged ≥70 years, with little variation between men and women (8.0% versus 6.1%; P=0.0003). Masked hypertension was more prevalent among men (21.1% versus 11.4%; P<0.0001). The age-specific prevalences of masked hypertension were 18.2%, 27.3%, 27.8%, 20.1%, 13.6%, and 10.2% among men and 9.0%, 9.9%, 12.2%, 11.9%, 14.7%, and 12.1% among women. In conclusion, this large collaborative analysis showed that the relation between daytime ambulatory and conventional BP strongly varies by age. These findings may have implications for diagnosing hypertension and its subtypes in clinical practice.

Citing Articles

Quantitative analysis of systemic perfusion and cerebral blood flow in the modeling of aging and orthostatic hypotension.

Cheng H, Dai J, Li G, Ding D, Li J, Zhang K Front Physiol. 2024; 15:1353768.

PMID: 39148746 PMC: 11324494. DOI: 10.3389/fphys.2024.1353768.


Blood pressure and renal function responses in workers exposed to lead for up to six years.

Yu Y, An D, Yang W, Verhamme P, Allegaert K, Nawrot T J Clin Hypertens (Greenwich). 2023; 25(12):1086-1095.

PMID: 37938055 PMC: 10710557. DOI: 10.1111/jch.14748.


What did we learn from the International Databases on Ambulatory and Home Blood Pressure in Relation to Cardiovascular Outcome?.

Asayama K, Stolarz-Skrzypek K, Yang W, Hansen T, Brguljan-Hitij J, Odili A Hypertens Res. 2023; 46(4):934-949.

PMID: 36737461 PMC: 10073019. DOI: 10.1038/s41440-023-01191-4.


Prediction of white-coat hypertension and white-coat uncontrolled hypertension using machine learning algorithm.

Shih L, Wang Y, Hung M, Cheng H, Shiao Y, Tseng Y Eur Heart J Digit Health. 2023; 3(4):559-569.

PMID: 36710891 PMC: 9779877. DOI: 10.1093/ehjdh/ztac066.


Hypertension in China: epidemiology and treatment initiatives.

Wang J, Zhang W, Li Y, Liu L Nat Rev Cardiol. 2023; 20(8):531-545.

PMID: 36631532 DOI: 10.1038/s41569-022-00829-z.


References
1.
Shaw B, Liang J, Krause N, Gallant M, McGeever K . Age differences and social stratification in the long-term trajectories of leisure-time physical activity. J Gerontol B Psychol Sci Soc Sci. 2010; 65(6):756-66. PMC: 2954334. DOI: 10.1093/geronb/gbq073. View

2.
Staessen J, Thijs L, Fagard R, OBrien E, Clement D, de Leeuw P . Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999; 282(6):539-46. DOI: 10.1001/jama.282.6.539. View

3.
Staessen J, Byttebier G, Buntinx F, Celis H, OBrien E, Fagard R . Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA. 1997; 278(13):1065-72. View

4.
Conen D, Tschudi P, Martina B . Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial. J Hum Hypertens. 2008; 23(2):122-9. DOI: 10.1038/jhh.2008.106. View

5.
Lee I, Shiroma E, Lobelo F, Puska P, Blair S, Katzmarzyk P . Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012; 380(9838):219-29. PMC: 3645500. DOI: 10.1016/S0140-6736(12)61031-9. View